A series of nanocomposite scaffolds comprised of dextran (Dex) and sol–gel derived bioactive glass ceramic
nanoparticles (nBGC: 0–16 (wt%)) were fabricated as bioactive scaffolds for bone tissue engineering. Scanning
electron microscopy showed Dex/nBGC scaffolds were consisting of a porous 3D microstructure with an average
pore size of 240 μm. Energy-dispersive x-ray spectroscopy illustrated nBGC nanoparticles were homogenously
distributed within the Dex matrix at low nBGC content (2 wt%), while agglomeration was observed at higher
nBGC contents. It was found that the osmotic pressure and nBGC agglomeration at higher nBGC contents leads to
increased water uptake, then reduction of the compressive modulus. Bioactivity of Dex/nBGC scaffolds was
validated through apatite formation after submersion in the simulated body fluid. Dex/nBGC composite scaffolds
were found to show improved human osteoblasts (HOBs) proliferation and alkaline phosphatase (ALP) activity
with increasing nBGC content up to 16 (wt%) over two weeks. Owing to favorable physicochemical and
bioactivity properties, the Dex/nBGC composite hydrogels can be offered as promising bioactive scaffolds for
bone tissue engineering applications.